Published in Adv Immunol on January 01, 1982
Three-dimensional structure of Fab R19.9, a monoclonal murine antibody specific for the p-azobenzenearsonate group. Proc Natl Acad Sci U S A (1989) 1.35
Immunoadsorption of Cryptococcus-specific suppressor T-cell factors. Infect Immun (1986) 1.03
Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice. Proc Natl Acad Sci U S A (1984) 1.00
Idiotypic manipulation in mice: BALB/c mice can express the crossreactive idiotype of A/J mice. Proc Natl Acad Sci U S A (1983) 0.98
Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm. Immunology (2008) 0.97
A mechanism responsible for the induction of H-2 restricted second order suppressor T cells. J Exp Med (1983) 0.95
Contrasuppression in autoimmunity. Abnormal contrasuppression facilitates expression of nephritogenic effector T cells and interstitial nephritis in kdkd mice. J Exp Med (1987) 0.86
Three-dimensional structure of two crystal forms of FabR19.9 from a monoclonal anti-arsonate antibody. Proc Natl Acad Sci U S A (1992) 0.86
Suppressor T-cell factor(s) display an altered pattern of Igh (immunoglobulin heavy chain locus) genetic restriction when developed in an Igh-congeneic host. Proc Natl Acad Sci U S A (1985) 0.81
The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. I. Spleen dendritic cells. Immunology (1992) 0.79
Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor. J Clin Invest (1994) 0.78
Isoelectric focusing spectra of anti-bacterial alpha-amylase antibody unique for antigen-induced suppression. Immunology (1986) 0.77
Structure of idiotopes associated with antiphenylarsonate antibodies expressing an intrastrain crossreactive idiotype. J Exp Med (1989) 0.76
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature (1985) 6.23
A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim (1999) 4.93
Quantitative investigations of idiotypic antibodies. VI. Idiotypic specificity as a potential genetic marker for the variable regions of mouse immunoglobulin polypeptide chains. J Exp Med (1972) 4.84
Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen. J Exp Med (1979) 3.35
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature (1989) 3.27
Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors. J Exp Med (1980) 3.21
Evidence for the linkage of the IGC H locus to a gene controlling the idiotypic specificity of anti-p-azophenylarsonate antibodies in strain A mice. J Exp Med (1973) 3.18
Quantitative investigations of idiotypic antibodies. I. Analysis of precipitating antibody populations. J Exp Med (1969) 3.10
Quantitative investigations of idiotypic antibodies. IV. Inhibition by specific haptens of the reaction of anti-hapten antibody with its anti-idiotypic antibody. J Exp Med (1970) 3.01
Evidence for control of synthesis of the varible regions of the heavy chains of immunoglobulins G and M by the same gene. Proc Natl Acad Sci U S A (1970) 2.96
Suppression of idiotypic specificities in adult mice by administration of antiidiotypic antibody. J Exp Med (1972) 2.93
Production of large amounts of antibodies in individual mice. J Immunol (1976) 2.93
Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell (1985) 2.75
Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell (1990) 2.58
Mechanisms of regulation of cell-mediated immunity. II. Induction and suppression of delayed-type hypersensitivity to azobenzenearsonate-coupled syngeneic cells. J Immunol (1978) 2.52
Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. J Immunol (1976) 2.42
Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells. J Exp Med (1979) 2.40
The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J Immunol (1988) 2.39
Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell (1989) 2.30
Presence on idiotype-specific suppressor T cells of receptors that interact with molecules bearing the idiotype. J Exp Med (1977) 2.29
The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell (1991) 2.24
Bound water molecules and conformational stabilization help mediate an antigen-antibody association. Proc Natl Acad Sci U S A (1994) 2.18
Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. I. Genetic control of delayed-type hypersensitivity by VH and I-A-region genes. J Exp Med (1979) 2.14
Distribution of a cross-reactive idiotypic specificity in inbred strains of mice. J Exp Med (1973) 2.13
The I-J subregion codes for determinats on suppressor factor(s) which limit the contact sensitivity response to picryl chloride. J Exp Med (1977) 2.07
Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production. Clin Immunol Immunopathol (1981) 2.05
Mechanisms of regulation of cell-mediated immunity. III. The characterization of azobenzenearsonate-specific suppressor T-cell-derived-suppressor factors. J Exp Med (1979) 1.99
Segregation at a locus determining an immunoglobulin genetic marker for the light chain variable region affects inheritance of expression of an idiotype. Proc Natl Acad Sci U S A (1977) 1.97
A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J (1999) 1.96
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum. Proc Natl Acad Sci U S A (1977) 1.93
Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene. Nature (1985) 1.88
Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide. J Immunol (1977) 1.87
A splenic requirement for the generation of suppressor T cells. J Immunol (1977) 1.86
Studies of structure and immunosuppression of cross-reactive idiotype in strain A mice. Immunol Rev (1977) 1.86
Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. J Immunol (1976) 1.83
Prevention of breast tumour development in vivo by downregulation of the p185neu receptor. Nat Med (1995) 1.81
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Idiotypic mimicry of biological receptors. Annu Rev Immunol (1986) 1.78
Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts. J Immunol (1977) 1.76
p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res (1990) 1.75
Genetic and molecular mechanisms of viral pathogenesis: implications for prevention and treatment. Nature (1982) 1.75
Enhancement by reducing agents of the transformation of human and rabbit peripheral lymphocytes. J Immunol (1970) 1.73
Impairment of antigen-presenting cell function by ultraviolet radiation. Proc Natl Acad Sci U S A (1979) 1.73
Suppressive mechanisms involving sensitization and tolerance in contact allergy. Immunol Rev (1980) 1.72
Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor. Proc Natl Acad Sci U S A (1985) 1.70
Requirement for cross-linkage in the stimulation of transformation of rabbit peripheral lymphocytes by antiglobulin reagents. J Immunol (1970) 1.68
Isolation from individual A/J mice of anti-rho-azophenylarsonate antibodies bearing a cross-reactive idiotype. J Exp Med (1975) 1.68
Frequency of occurrence of idiotypes associated with anti-p-azophenylarsonate antibodies arising in mice immunologically suppressed with respect to a cross-reactive idiotype. J Exp Med (1977) 1.67
The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state. Eur J Immunol (1977) 1.66
Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.65
Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med (1982) 1.64
Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc Natl Acad Sci U S A (1992) 1.63
Quantitative investigations of idiotypic antibodies. II. Nonprecipitating antibodies. J Exp Med (1970) 1.63
Antigen- and receptor-driven regulatory mechanisms. I. Induction of suppressor T cells with anti-idiotypic antibodies. J Exp Med (1979) 1.62
T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo. J Immunol (1986) 1.62
Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J Pathol (2001) 1.61
Preparation of F(ab')2 fragments from mouse IgG of various subclasses. J Immunol Methods (1983) 1.57
Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Proc Natl Acad Sci U S A (1986) 1.56
Suppression of idiotype and generation of suppressor T cells with idiotype-conjugated thymocytes. J Exp Med (1979) 1.56
Immunological suppression of idiotypic specificities. Transplant Rev (1975) 1.55
Relative labilities of the two types of interchain disulfide bond of rabbit gamma G-immunoglobulin. J Biol Chem (1965) 1.53
Stage- and tissue-specific expression of the neu oncogene in rat development. Proc Natl Acad Sci U S A (1987) 1.52
Increased detection of hepatitis C virus infection in commercial plasma donors by a third-generation screening assay. Transfusion (1995) 1.52
The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene (1994) 1.51
Reactivity of type-specific monoclonal antibodies with Staphylococcus aureus clinical isolates and purified capsular polysaccharide. Infect Immun (1985) 1.51
Heterogeneity of an intrastrain cross-reactive idiotype associated with anti-p-azophenylarsonate antibodies of A/J mice. J Immunol (1980) 1.51
Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci U S A (1996) 1.49
Antigen- and receptor-driven regulatory mechanisms. III. Induction of delayed type hypersensitivity to azobenzenearsonate with anti-cross-reactive idiotypic antibodies. J Exp Med (1980) 1.48
Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. J Exp Med (1984) 1.48
Selective suppression of the major idiotypic component of an antihapten response by soluble T cell-derived factors with idiotypic or anti-idiotypic receptors. J Exp Med (1980) 1.47
Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes. Nat Biotechnol (1997) 1.47
Cell receptors for the mammalian reovirus. I. Syngeneic monoclonal anti-idiotypic antibody identifies a cell surface receptor for reovirus. J Immunol (1983) 1.46
Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol (2000) 1.44
The winged helix/forkhead transcription factor Foxq1 regulates differentiation of hair in satin mice. Genesis (2001) 1.44
Nucleic acid sequence of an internal image-bearing monoclonal anti-idiotype and its comparison to the sequence of the external antigen. Proc Natl Acad Sci U S A (1986) 1.43
Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo. Oncogene (1988) 1.43
Quantitative investigations of idiotypic antibodies. 3. Persistence and variations of idiotypic specificities during the course of immunization. J Exp Med (1970) 1.43
Antigen- and receptor-driven regulatory mechanisms. II. Induction of suppressor T cells with idiotype-coupled syngeneic spleen cells. J Exp Med (1979) 1.42
Control of MHC restriction by TCR Valpha CDR1 and CDR2. Science (1996) 1.40
Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo. J Immunol (1978) 1.40
The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Oncogene (2001) 1.39
Requirements for prolonged suppression of an idiotypic specificity in adult mice. J Exp Med (1973) 1.38
YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene (2012) 1.36
Three-dimensional structure of Fab R19.9, a monoclonal murine antibody specific for the p-azobenzenearsonate group. Proc Natl Acad Sci U S A (1989) 1.35
Idiotype-specific T cell immunity. I. Generation of effector and suppressor T lymphocytes reactive with myeloma idiotypic determinants. J Immunol (1980) 1.35
Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors. Proc Natl Acad Sci U S A (1985) 1.34